Crystallization and atomic resolution X-ray diffraction analysis of antichymotrypsin variants

5Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Crystals of two recombinant antichymotrypsin (rACT) variants have been prepared: variant rACT-T345R crystallizes in space group P21 (a = 109.2 Å, b = 79.4 Å, c = 111.9 Å, β = 116.3°, with 2 molecules in the asymmetric unit), and variant ACT' crystallizes in space group P21221 (a = 69.7 Å, b = 77.2 Å, c = 83.8 Å, with one molecule in the asymmetric unit). The latter variant is an engineered dimer having the P3-P3′ hexapeptide sequence of the related serpin, α1-proteinase inhibitor, substituted for the corresponding wild-type sequence. Crystals of each variant diffract to a limiting resolution 2.5 Å, which represents the best diffraction yet achieved for a crystalline, inhibitory serpin. The exceptional quality of ACT crystals probably arises from favorable protein-protein interactions as well as a stabilizing disulfide crosslink engineered between the monomers. © 1993 Academic Press, Inc.

Cite

CITATION STYLE

APA

Katz, D. S., Wei, A., Zhong, Q., Rubin, H., Cooperman, B. S., & Christianson, D. W. (1993). Crystallization and atomic resolution X-ray diffraction analysis of antichymotrypsin variants. Biochemical and Biophysical Research Communications, 196(2), 752–757. https://doi.org/10.1006/bbrc.1993.2313

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free